Quercetin is a strong antioxidant flavonoid with several bioactive properties such as anti-11 inflammatory and anticarcinogenic activities, becoming an interesting compound to be 12 incorporated into pharmaceutical, cosmetic or food products. However, these applications are 13 limited «by the low bioavailability of this flavonoid. Quercetin is poorly soluble in aqueous 14 media, such as gastrointestinal fluids, being also degraded by gut flora. Thus, it is necessary the 15 development of quercetin's formulations capable of improving its water solubility resulting in 16 increased bioavailability and thus higher biological activity of this compound. 17
Introduction 31
Quercetin (3,3',4',5,7-Pentahydroxyflavone), one of the most representative member of the 32 flavonoid family with high antioxidant activity, is commonly found in several fruits and 33 vegetables like onions, apples, grapes or strawberries, as well as in red wine or green/black tea 34 industries due to its bioactive properties, such as anti-inflammatory, anti-proliferative and 37 neuroprotective effects (Boots, Haenen, & Bast, 2008; Priprem et al., 2008) . In order to achieve 38 quercetin plasma's concentration above 10 mM required for obtaining pharmacological 39 activity, the ingestion of quercetin-enriched foods or supplements could not be enough due to 40 the low bioavailability of this flavonoid (Russo, Spagnuolo, Tedesco, Bilotto, & Russo, 2012) . 41
The low water solubility (2ppm at 25ºC to 60 ppm at 100ºC) allied with gastrointestinal 42 degradation limits quercetin's biological effects in vivo (Souza et Formulations of quercetin using different methods and distinct carrier materials have been 47 container in order to obtain a better dispersion of the micelles. In this work, particle size 174 measurements are reported as volume distribution and defined as the average diameter (d 0.5 ). 175
Encapsulation efficiency (EE) 176
For the quercetin's water suspensions stabilized with starch the Encapsulation Efficiency (EE) 177 was determined through Ultraviolet-visible spectrophotometry, while in the suspensions 178 stabilized with lecithin or β-glucan, due to the interference of these carrier materials on UV 179 assays, this parameter was determined by HPLC. 180
For UV-Vis measurements, the suspensions were previously centrifugated at 7800rpm (5min) 181
and diluted in water. The concentration of quercetin was determined using a UV-Visible 182
Spectrophotometer (Shimadzu UV-2550, λ= 375 nm). Calibration was obtained by using 183 standard samples with concentrations between 3 and 12μg/mL, using ethanol as solvent. 184 HPLC analysis of quercetin was performed in accordance with a method previously reported 185 The absorbance is proportional to the amount of quercetin dispersed in solution which 196 corresponds to the encapsulated quercetin. Non-encapsulated quercetin can correspond 197 either to quercetin precipitated as big crystals and not stabilized in the suspension, or toquercetin that has undergone degradation during the process. The encapsulation efficiency is 199 reported as the ratio between the amount of flavonoid dispersed in solution and total 200 quercetin amount in the initial feed. 201
Structural characterisation 202
Infrared spectra of the suspensions and pure materials were recorded on a Bruker ALPHA FT-IR 203 apparatus equipped with a Platinum ATR sampling module including a diamond crystal. The 204 suspensions were centrifuged at 13300rpm during 30min. The supernatant was removed and 205 the sample pellet's was submitted to further evaporation of water at -0.09MPa and 35ºC for 206 48h. The pellet was then used to perform FTIR. The spectra in the range from 4000 to 400 cm -1
207
were the average of 64 scans at a resolution of 2cm -1 . The ATR signal was transformed to 208
Transmittance and the obtained spectra was normalised after the baseline correction. 209
Cryo-TEM 210
Cryo-TEM analysis were performed through a method already described (Melanson, 2009) . 211
Briefly, 4μl of sample was deposited on a rack C-Flat 1.2/1.3, which was previously 212 hydrophilized by a plasma cleaner. A blotting is performed on either side of the filter paper 213 grid during 4s where, afterwards, liquid ethane is introduced in order to freeze the samples, 214 avoiding the formation of crystals (Gatan Cryoplunge 3). Samples are maintained in liquid 215 nitrogen until their transfer to the holder (Gatan Cryotransfer 626). JEOL JEM-FS2200 HRP 200 216 kV TEM equipment with electron filtering was used to perform the TEM images. 217
Stability of suspensions 218
One of the aqueous suspensions with the best relation between EE and final quercetin's 219 concentration was chosen for stability examination. Some authors demonstrated that it's 220 possible to increase the stability of lecithin, reducing the appearance of its agglomerates and 221 increase drug's solubility by adding glycerol (G), as co-solvent, to aqueous lecithin dispersions water phase was prepared in order to compare the physicochemical properties of the 225 suspension without it. The stability examination was performed through the assessement of 226 micellar particle size, presence of crystals, quercetin's concentration and antioxidant activity of 227 the suspensions after 75 days of storage in a refrigerated dark room (10ºC). 228
The assessment of antioxidant activity was performed through oxygen radical absorption 229 capacity (ORAC) assay, which was carried out by a method previously described (Ou, Huang, order to guarantee the formation of micelles. In the first experiments performed in this work, 253 the encapsulation of quercetin in modified OSA-starch was studied. Table 1 Overall, the encapsulation efficiency was not higher than 10%, while the particle size was in 263 the range of micrometer, showing that modified starch is not an appropriate emulsifier to 264 encapsulate quercetin. 265
The highest percentage of encapsulated quercetin was reached when low starch 266 concentrations were used, while particle size increased when the concentration of the 267 emulsifier increased. In general, in a successful encapsulation the opposite trends of variation 268 with the concentration of carrier are expected, as observed by de Paz et al in the 269 encapsulation of -carotene in starch (de Paz et al., 2014) . Therefore, this result confirms that 270 the OSA-modified starch is not a suitable carrier for quercetin, as it does not favor the 271 encapsulation or reduction of particle size of the compound, and on the contrary it evenprecludes it, probably due to the higher viscosity and increased mass transfer resistances in 273 the samples with higher starch concentrations. 274
Regarding the influence of the concentration of quercetin, in general high concentrations of 275 quercetin implied lower encapsulation efficiency and higher particle size. This could be 276 explained owing to the fact that at high concentrations of quercetin it gets more difficult for 277 the flavonoid to dissolve after M-1, leading to lower encapsulation efficiency and higher 278 particle size due to the presence of quercetin crystals. 279
An increase of the organic-water ratio led to an increase of both particle size and 280 encapsulation efficiency. Probably the higher initial volume of ethyl acetate used led to the 281 formation of an emulsion with larger droplet size and thus the formation of bigger particles 282 inside the micelles. A higher percentage of the organic solvent may also lead to increased 283 dissolution of quercetin, resulting in higher final EE. 284
Lecithin 285
The encapsulation of quercetin by using lecithin as the emulsifer was also studied in this work. 286
Since this emulsifier has a critical micelle concentration around 20g/L (experimentally 287 determined, data not shown), equal or higher concentration of lecithin was used in order to 288 guarantee the formation of micelles , & 289
Cocero, 2011). In Table 2 the operating conditions of the experiments performed and the 290 results obtained are displayed. 291
The experiments started with the determination of the organic-water ratio and lecithin's 293 concentration most suitable to produce stable emulsions (E12-E15), using a concentration of 294 quercetin soluble in ethyl acetate at ambient temperature (1g/L). In fact, it was found that the 295 experiment performed with organic-water ratio and lecithin's concentration at higher values(E13) led to the formation of an unstable emulsion, with separation of phases immediately 297 after its production. Overall, the emulsions produced proved to be more stable at lower 298 lecithin concentration and lower organic solvent:water ratio tested. Moreover, in experiments 299 E12-E14, aggregates of lecithin precipitated during the evaporation step, perhaps due to the 300
Thus, experiments from E16-E19 were performed using a concentration of lecithin fixed at 306 25g/L, further reduced organic solvent:water ratio fixed at 0.35 and variable concentrations of 307 quercetin. The emulsion's internal phase diameter was determined by turbiscan, revealing that 308 the diameter of the discontinuous phase was in general below 5μm. Moreover, none of the 309 emulsions showed the presence of quercetin's crystals, revealing a good encapsulation of this 310 flavonoid. Nevertheless, crystals of quercetin precipitated in the flask during the evaporation 311 of ethyl acetate from the emulsions E18 and E19, revealing that quercetin's concentration of 312 7.5 and 10g/L, respectively, may be too high for efficient encapsulation. The presence of 313 crystals in these experiments after solvent removal was confirmed by optical microscopy. 314
Microscope pictures of the emulsions and suspensions can be seen in figure 2. 315
The final particle of the quercetin-loaded micelles was in the nanometer range. Regarding 317 encapsulation efficiency, almost 76% was achieved for experiment E16, where the final 318 quercetin's concentration in the aqueous suspension was 260ppm. Experiments E17, E18 and 319 E19 show lower EE, probably due to the higher initial concentration of quercetin used, yet 320 showing higher final quercetin's concentration (E19 shows a concentration of 630ppm). In Figure 3 it is possible to verify that the EE decreased as the initial concentration of quercetin 322 used increased. However, final quercetin's concentration in the suspension increased as the 323 initial concentration of quercetin used increased, though this increase was first proportional, 324 yet reaching a plateau at 630ppm. This value could represent a saturation limit point, where 325 no more quercetin could be solubilised in the lecithin-aqueous suspension. 326
(FIGURE 3) 327
Lecithin showed to be a good emulsifier for the encapsulation of quercetin. In fact, the ability 328 of these two compounds to form chain-like structures linked by hydrogen bonds has been 329 already reported and demonstrated with nuclear magnetic resonance spectroscopy, being 330 these structures called phenolipids (Nasibullin, Nikitina, Afanas'eva, Nasibullin, & Spirikhin, 331 2002). Furthermore, there seems to exist a synergism between lecithin and quercetin due to 332 the formation of these bonds, resulting in an increased antioxidant potential (Ramadan, 2012 , 333
2014). 334
In Fig.4 it is possible to see the Cryo-TEM pictures taken to the suspension resulting from 335 experiment E16. 336
(FIGURE 4) 337
By observing the Cryo-TEM pictures of lecithin's water suspension (Fig 4. a) it is possible to see 338 multivesicular and multilamellar vesicular formulations of the emulsifier with particle size 339 around 100nm (Varona et al., 2011) . Nevertheless, regarding the quercetin aqueous 340 suspensions, it is possible to verify the presence of small vesicles around 100nm with dark 341 double layers (Fig. 4 b) and c)) probably due to presence of quercetin in this area. Moreover, in 342 
β-Glucan 363
The encapsulation of quercetin through the use of β-Glucan as emulsifier was also performed 364 in this work. 365
Since this emulsifier has a critical micelle concentration around 2g/L (experimentally 366 determined, data not shown), higher concentration of β-Glucan (15g/L) was used in order to 367 guarantee the formation of micelles. Moreover, β-Glucan has low oral bioavailability, due to its 368 poor absorption, and its complexation with lecithin was suggested to overcome this 369 undesirable characteristic (Veverka et al., 2014) . For that purpose, lecithin was also used insome experiments, with a mass ratio between β-Glucan and Lecithin varied according to 371
Veverka et al (Veverka et al., 2014 ). Quercetin's concentration of 1g/L was chosen for these 372 experiments. In Table 3 it is displayed the operating conditions of the experiments performed 373 and the results obtained. 374
(TABLE 3) 375
Emulsions from experiments performed with mixtures of surfactants, E21-E23, presented 376 some carrier's agglomerates. Nevertheless, emulsion from experiment E20 and stabilized just 377 with β-glucan, did not show these aggregates. It seems that mixtures of β-glucan and lecithin 378 form complexes with tendency to precipitate without improving the stability of the emulsions. 379
In fact, in experiments performed with both emulsifiers, the precipitation of the lecithin:β-380 glucans increased during the evaporation step. Nevertheless, none of the emulsions showed 381 the presence of quercetin's crystals, being the diameter of the discontinuous phase in general 382 below 4μm. According to turbiscan measurements, the sample that contained higher 383 concentration of lecithin, E23, showed higher diameter of organic solvent droplets. Still, it is 384 important to remember that turbiscan only provides mean particle size value but not the 385 dispersion of this value, hence the differences between turbiscan's values and optical 386 microscope images. 387
Regarding experiment E20, crystals of quercetin precipitated in the flask during the 388 evaporation of the emulsions, which was confirmed by optical microscopy. β-Glucan did not 389 seem to be a good carrier/emulsifier to encapsulate this flavonoid, and so, higher 390
concentrations of quercetin were not tested. The final particle of the quercetin-loaded 391 micelles was in the micrometer range. In the case of E20, the presence of quercetin's crystals 392 contributed for the micrometer size, whereas in the samples E21-E23 the presence of carrier's 393 agglomerates contributed to this particle size. Comparing E20 and E22, it is possible to see that 394 the addition of lecithin increased the particle size due to the formation of lecithin:β-glucancomplexes (Veverka et al., 2014) . Nevertheless, the addition of more lecithin (E21 and E23) led 396 to a reduction of particle size, probably due to the formation of higher amount of small sized 397 quercetin encapsulated particles. 398
Regarding the encapsulation efficiency, it is possible to verify that comparing E20 and E22, the 399 addition of lecithin to the system led to a decrease of EE. The addition of lecithin led to the 400 complexation of the carriers, and their further precipitation. Perhaps there is a competition 401 between quercetin and lecithin for the complexation with β-glucan, resulting in less EE in E22 402 comparing with E20. 403
Nevertheless, as the amount of the lecithin increased in β-glucan:lecithin mixtures 404 (E22<E21<E23), so as increased the EE of the system. These values are in agreement with the 405 reduction of particle size in these samples, as discussed previously. Perhaps in experiment E23 406
there is a higher portion of free lecithin, not complexed with β-glucan, to interact with 407 quercetin, increasing its encapsulation. This fact reinforces the capacity of lecithin to 408 encapsulate quercetin 409
Stability 410
Experiment E17 was repeated with and without the inclusion of glycerol in order to evaluate 411 and compare their stability. For that purpose, the micellar particle size, presence of crystals, 412 quercetin's concentration and antioxidant activity of the resulting suspensions were measured 413 after 75 days of storage. During this period, the aqueous solutions were stored in a 414 refrigerated room at temperatures around 10ºC and protected from light. The refrigeration 415 condition was chosen for the stability study since it is recommended as the storage condition 416 for the phospholipids (Date et al., 2011) . Results are reported in Table 4 . 417
(TABLE 4) 418
As presented in this table, the sample prepared with glycerol as co-solvent maintained 419 colloidal stability at the end of one month and a half, with no significant change in its particlesize, indicating good stability during this period. In contrast, the sample without glycerol nearly 421 tripled its size after the same period, being this value even higher after two months and a half 422 after its preparation. 423
Evaluating the shape of the size distribution, shown in Fig. 6 , the distribution of the sample 425 freshly prepared have main peak in the nanometers range, corresponding to quercetin 426 particles that were successfully encapsulated, and other peaks at sizes above 1 µm possibly 427 corresponding to quercetin's crystals and lecithin's agglomerates. During storage, the peaks 428 above 1 µm are displaced to considerably higher particle sizes, indicating that these bigger 429 particles are becoming more agglomerated and further destabilizing the suspension due to 430 their higher size. The addition of a co-solvent is essential for an adequate stability of the 431 formulation, avoiding not only the agglomeration of lecithin, but also delaying the appearance 432 of quercetin's crystals. In fact, in the sample prepared without glycerol, the appearance of 433 flavonoid's crystals was observed shortly after fifteen days of preparation. Regarding 434 encapsulation efficiency, the addition of a co-solvent appeared to slightly enhance the 435 solubility of quercetin in aqueous media. Nevertheless, the stability of quercetin over storage 436
was similar in the two tested samples. 437 Table 4 
